cbdMD, Inc. (YCBD)

cbdMD Income Statement

Financials in millions USD. Fiscal year is October - September.

Year	2023	2022	2021	2020	2019
Revenue	24.16	35.4	44.48	41.88	23.65
Revenue Growth (YoY)	-31.77%	-20.41%	6.20%	77.09%	5051.82%
Cost of Revenue	9.18	13.07	14.5	15.51	9.14
Gross Profit	14.98	22.34	29.99	26.37	14.51
Selling, General & Admin	24.25	39.65	49.6	43.95	29.31
Other Operating Expenses	13.22	61.47	0	0	0
Operating Expenses	37.47	101.12	49.6	43.95	29.31
Operating Income	-22.49	-78.78	-19.62	-17.58	-14.8
Interest Expense / Income	0	0	0.03	-0.04	0
Other Expense / Income	0.45	-8.7	4.64	-28.8	37.99
Pretax Income	-22.94	-70.08	-24.29	11.26	-52.79
Income Tax	0	0	-0.9	-1.35	-2.36
Net Income	-22.94	-70.08	-23.39	12.6	-50.43
Preferred Dividends	4	4	2.55	0.37	0
Net Income Common	-26.94	-74.09	-25.95	12.24	-50.43
Shares Outstanding (Basic)	2	1	1	1	0
Shares Outstanding (Diluted)	2	1	1	1	0
Shares Change	52.31%	8.76%	21.62%	152.54%	130.80%
EPS (Basic)	-13.32	-55.80	-21.15	12.60	-126.90
EPS (Diluted)	-13.32	-55.80	-21.15	12.60	-
Free Cash Flow	-4.6	-15.66	-14.44	-11.98	-16.58
Free Cash Flow Per Share	-2.27	-11.79	-11.82	-12.22	-41.70
Gross Margin	62.01%	63.09%	67.41%	62.96%	61.37%
Operating Margin	-93.10%	-222.52%	-44.10%	-41.98%	-62.56%
Profit Margin	-111.53%	-209.26%	-58.34%	29.21%	-213.21%
Free Cash Flow Margin	-19.04%	-44.22%	-32.45%	-28.61%	-70.08%
Effective Tax Rate	-	-	-	-11.95%	-
EBITDA	-20.01	-67.11	-22.01	13.12	-52.5
EBITDA Margin	-82.84%	-189.57%	-49.48%	31.32%	-221.96%
Depreciation & Amortization	2.93	2.97	2.25	1.9	0.29
EBIT	-22.94	-70.08	-24.26	11.22	-52.79
EBIT Margin	-94.96%	-197.96%	-54.54%	26.78%	-223.19%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).